UNSPSC 51123113: Tocainide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C11H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 27DXO59SAN, chemically known as 2-amino-n-(2,6-dimethylphenyl)propionamid but more generally known as tocainide, which bears US NIH Compound Identifier 38945. European Medicines Agency schedules Tocainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11136MIG.

UNSPSC 51123113 Tocainide is a Commodity code that encompasses emergency medical pharmaceutical products purchased by state and local public safety agencies. In practice, state and local buyers under this code procure advanced life support medications—including tocainide and related antiarrhythmic and cardiovascular agents—for use by fire rescue services, emergency medical services, and hospital systems. The work involves supplying pharmaceutical products meeting strict expiration, quality, and compliance standards, with vendors responsible for packaging, labeling, OSHA Hazard Communication compliance, shelf-life management, and expedited delivery windows. Issuing bodies under the code include municipal purchasing departments acting on behalf of fire rescue operations, county health systems, and regional emergency services coordinators. Vendors must hold appropriate pharmaceutical licenses, maintain cold-chain or controlled-environment logistics where required, warrant product integrity for defined periods, and often accept replacement obligations for expired stock before contracted expiration dates.

Geographic activity under the code centers on Florida based on recent solicitation volume. The City of Tampa's Purchasing Department issued a sealed-bid IFB (Bid No. 26P00188) on April 24, 2026, for Advanced Life Support Medications to supply Tampa Fire Rescue, with a due date of April 8, 2026, an estimated contract value of $40,000.00, and a one-year term with options to renew for two additional one-year periods. The bid called for 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with all medications required to maintain a nine-month minimum expiration date from acceptance and delivery within ten calendar days of order. The solicitation included a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount capped at $10,000 and required vendors to supply Safety Data Sheets compliant with OSHA HCS and WCAG 2.2 Level AA accessibility documentation.